REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 80 filers reported holding REPROS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $251,000 | -50.9% | 33,762 | -52.8% | 0.01% | -53.8% |
| Q2 2015 | $511,000 | -16.1% | 71,508 | +0.8% | 0.01% | -13.3% |
| Q1 2015 | $609,000 | -14.8% | 70,908 | -1.1% | 0.02% | -78.9% |
| Q4 2014 | $715,000 | -27.9% | 71,705 | -28.4% | 0.07% | +173.1% |
| Q3 2014 | $991,000 | +118.8% | 100,121 | +282.1% | 0.03% | +116.7% |
| Q2 2014 | $453,000 | -83.7% | 26,205 | -74.8% | 0.01% | -84.2% |
| Q3 2013 | $2,786,000 | – | 103,945 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,096,000 | 1.86% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,353,000 | 0.56% |
| RTW INVESTMENTS, LP | 229,364 | $1,640,000 | 0.48% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 182,500 | $1,305,000 | 0.41% |
| GENERAL AMERICAN INVESTORS CO INC | 601,553 | $4,301,000 | 0.35% |
| Baker Brothers Advisors | 1,955,944 | $13,985,000 | 0.12% |
| CQS Cayman LP | 240,000 | $1,716,000 | 0.10% |
| Gruss Capital Management LP | 304,000 | $2,174,000 | 0.08% |
| J. Goldman & Co LP | 101,881 | $728,000 | 0.04% |
| Squarepoint Ops LLC | 18,800 | $134,000 | 0.04% |